Assessing risk of breast cancer recurrence

US10489904B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10489904-B2
Application numberUS-201615374998-A
CountryUS
Kind codeB2
Filing dateDec 9, 2016
Priority dateJun 10, 2014
Publication dateNov 26, 2019
Grant dateNov 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The subject disclosure presents systems and computer-implemented methods for assessing a risk of cancer recurrence in a patient based on a holistic integration of large amounts of prognostic information for said patient into a single comparative prognostic dataset. A risk classification system may be trained using the large amounts of information from a cohort of training slides from several patients, along with survival data for said patients. For example, a machine-learning-based binary classifier in the risk classification system may be trained using a set of granular image features computed from a plurality of slides corresponding to several cancer patients whose survival information is known and input into the system. The trained classifier may be used to classify image features from one or more test patients into a low-risk or high-risk group.

First claim

Opening claim text (preview).

The invention claimed is: 1. An image processing method for analyzing at least first and second images obtained from an early stage breast cancer biopsy tissue sample, the tissue sample being ER-positive and HER2-negative, the tissue sample being marked by multiple stains for identification of biological features, the method comprising: acquiring a predetermined plurality of prognostic marker-specific biological features by performing an image analysis on the at least first and second images individually, wherein each of the acquired prognostic marker-specific biological features has at least one numerical value assigned thereto that is descriptive of the biological feature, and at least one of the acquired marker-specific biological features includes a nucleus blob shape feature, a nucleus blob area feature, a nucleus blob compactness feature, a nucleus blob density feature, a normalized color feature, an absolute color feature, a nearest neighbor feature, a center vote strength, an annular region based feature, or a blob topography feature; computing a predefined plurality of prognostic inter-marker features by calculating combinations of numerical values of predefined pairs of the marker-specific biological features acquired from different ones of the at least first and second images; and entering (i) the plurality of acquired prognostic marker-specific biological features and (ii) the plurality of prognostic inter-marker features into a trained predictor, wherein the trained predictor correlates (i) and (ii) with breast cancer recurrence data and cross-validates performance of the trained predictor; wherein the predictor outputs a first signal or a second signal in response to the entry of the plurality of prognostic marker-specific biological features and prognostic inter-marker features, the first signal being indicative of a requirement for adjuvant chemotherapy and the second signal being indicative of the adjuvant chemotherapy being unnecessary. 2. The method of claim 1 , the calculation of at least some of the combinations being performed by multiplying the numerical value of the acquired biological feature of one of the at least first and second image by the numerical value of the acquired biological feature of the other of the at least first and second image. 3. The method of claim 2 , wherein the predetermined plurality of prognostic marker-specific biological features and the predefined plurality of prognostic inter-marker features are determined by L1-regularized logistic regression, and the trained predictor is obtained by L1-regularized logistic regression. 4. The method of claim 1 , the calculation of at least some of the combinations being performed by calculating a correlation coefficient indicative of a spatial correlation of the marker-specific biological features in each pair of the predefined pairs. 5. The method of claim 1 , further comprising acquiring a multi-channel image from the tissue sample being stained by multiple stains and obtaining the at least first and second images by unmixing the multi-channel image. 6. The method of claim 1 , wherein the at least first and second images are obtained by slicing the tissue sample into at least first and second tissue slices and individually staining the first and second tissue slices for acquisition of the respective at least first and second images. 7. The method of claim 6 , the at least first and second slices being adjacent slices and having a thickness of between 2 μm to 10 μm. 8. The method of claim 6 wherein the at least first and second slices are adjacent slices having a thickness of 6 μm.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10489904B2 cover?
The subject disclosure presents systems and computer-implemented methods for assessing a risk of cancer recurrence in a patient based on a holistic integration of large amounts of prognostic information for said patient into a single comparative prognostic dataset. A risk classification system may be trained using the large amounts of information from a cohort of training slides from several pa…
Who is the assignee on this patent?
Ventana Med Syst Inc, Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification G06T7/0012. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).